NPRA Banner

               
Product Search   QUEST3+ System   Enquiries   Sitemap  

[CLOSED] Public Consultation: Malaysian Guideline for Bioequivalence Inspection 2nd Edition

User Rating: 5 / 5

Star ActiveStar ActiveStar ActiveStar ActiveStar Active
 

The NPRA and Bioequivalence & Ethics Committee Section (BEEC) is in the process of updating and modernising the Malaysian Guideline for Bioequivalence Inspection and would like to seek your inputs to further improve on the clarity and transparency of its contents. We invite you to provide your inputs at the following link: https://tinyurl.com/MGBEI-UPC 

 

We also invite you to complete a short survey (found in the link above) related to the publication of inspection compliance status on the NPRA website. Please read through the instructions on how to provide your inputs carefully to ensure that your opinions are captured. 

 

We would like to thank you for your time and valued inputs in this public consultation.

 

Public consultation period: 8 April 2024 - 6 May 2024

 

UPDATE:-

The NPRA and BEEC Section would like to thank you for your feedback and inputs during the public consultation of the Malaysian Guideline for Bioequivalence Inspection 2nd Edition. We would also like to take the opportunity to thank you for your feedback in the short survey to publish our inspection outcomes on the NPRA website. We are currently reviewing your valued inputs and will publish the outcome of the public consultation and survey in a formal report.

 

Thank you.

 

-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

 

NPRA dan BEEC sedang dalam proses mengemaskini Malaysian Guideline for Bioequivalence Inspection dan ingin mendapatkan pendapat anda untuk menambahbaik isi kandungan garispanduan tersebut agar lebih jelas dan telus. Kami menjemput anda untuk memberi input di pautan berikut: https://tinyurl.com/MGBEI-UPC 

 

Kami juga menjemput anda untuk melengkapkan kaji selidik ringkas (di pautan yang sama) berkaitan dengan penerbitan status kepatuhan hasil pemeriksaan di laman sesawang NPRA. Sila baca arahan dengan teliti berhubung cara untuk memberi input anda bagi memastikan pendapat anda diterima oleh kami.

 

Kami ingin mengucapkan terima kasih atas masa dan pendapat yang anda beri dalam seranta awam ini.

 

Tempoh seranta awam: 8 April 2024 - 6 Mei 2024

 

KEMASKINI:-

Pihak NPRA dan Seksyen BEEC ingin mengucapkan terima kasih atas maklum balas dan input anda semasa seranta awam Malaysian Guideline for Bioequivalence Inspection Edisi Kedua. Kami juga ingin mengambil kesempatan ini untuk mengucapkan terima kasih atas maklum balas anda dalam soal selidik ringkas berhubung penerbitan hasil pemeriksaan di laman sesawang NPRA. Kami sedang meneliti semua maklum balas yang diterima dan akan menerbitkan hasil seranta awam dan soal selidik dalam laporan rasmi.

 

Terima kasih.

 

 

 

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Site Last Modified

  • Last Modified: Monday 11 November 2024, 23:17:14.

Search

Main Menu English